InvestorsHub Logo
Followers 19
Posts 901
Boards Moderated 0
Alias Born 05/31/2013

Re: dr_lowenstein post# 29276

Saturday, 03/21/2015 6:28:14 PM

Saturday, March 21, 2015 6:28:14 PM

Post# of 48316

This collaboration is significant because of the speed of being able to get into a clinical trial to test our hypothesis and as a critical and positive step in the development of IL-12 immunotherapy.



http://punitdhillon.com/2014/11/25/oncosec-ucsf-and-merck-initiate-a-landmark-phase-iib-combination-trial-of-breakthrough-drug-keytruda-and-immunopulse-to-treat-metastatic-melanoma/